Login / Signup

Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Ayodele OdutayoFrancesco CosentinoRichard E PratleySamuel Dagogo-JackDarren K McGuireRobert FrederichWei FuChristopher P CannonDavid Z I Cherneynull null
Published in: Diabetes, obesity & metabolism (2024)
Keyphrases
  • cardiovascular disease
  • type diabetes
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • cardiovascular risk factors
  • randomized controlled trial
  • cardiovascular events
  • open label
  • metabolic syndrome
  • double blind